Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to -$0.27.

  • Ocular Therapeutix's EPS (Basic) rose 357.14% to -$0.27 in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.42, marking a year-over-year decrease of 1360.0%. This contributed to the annual value of -$1.42 for FY2025, which is 1639.34% down from last year.
  • Per Ocular Therapeutix's latest filing, its EPS (Basic) stood at -$0.27 for Q4 2025, which was up 357.14% from -$0.38 recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's EPS (Basic) ranged from a high of $0.04 in Q1 2021 and a low of -$0.49 during Q1 2024
  • For the 5-year period, Ocular Therapeutix's EPS (Basic) averaged around -$0.23, with its median value being -$0.26 (2023).
  • In the last 5 years, Ocular Therapeutix's EPS (Basic) soared by 11578.95% in 2021 and then plummeted by 210000.0% in 2024.
  • Over the past 5 years, Ocular Therapeutix's EPS (Basic) (Quarter) stood at -$0.05 in 2021, then crashed by 300.0% to -$0.2 in 2022, then crashed by 75.0% to -$0.35 in 2023, then increased by 20.0% to -$0.28 in 2024, then rose by 3.57% to -$0.27 in 2025.
  • Its EPS (Basic) was -$0.27 in Q4 2025, compared to -$0.38 in Q3 2025 and -$0.39 in Q2 2025.